US Patent Issued to Dana-Farber Cancer Institute on April 22 for "Inhibitors of cyclin-dependent kinase 7 and uses thereof" (American, Chinese Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,126, issued on April 22, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"Inhibitors of cyclin-dependent kinase 7 and uses thereof" was invented by Nathanael S. Gray (Boston), Tinghu Zhang (Brookline, Mass.), Nicholas Paul Kwiatkowski (Brookline, Mass.), Jie Jiang (Brookline, Mass.), Mingfeng Hao (Hefei, China) and Zhixiang He (Brookline, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs thereof. The compounds of the present...